Reference
Correia I, et al. Long-term effectiveness and safety of natalizumab in a Portuguese population. International Immunopharmacology 46: 105-111, May 2017. Available from: URL: http://doi.org/10.1016/j.intimp.2017.03.006 - Portugal
Rights and permissions
About this article
Cite this article
Natalizumab. Reactions Weekly 1650, 210 (2017). https://doi.org/10.1007/s40278-017-29742-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-29742-x